journavx - Search News

New non-opioid painkiller Journavx approved by FDA

FDA Approves New Non-Opioid Painkiller Journavx for Acute Pain | Watch

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx (suzetrigine), for adults with moderate to severe acute pain. Developed by Vertex Pharmaceuticals,

U.S. News & World Report · 3d

What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.

TribLIVE.com · 11h

Newly approved painkiller Journavx is 'potentially groundbreaking'

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to local medical professionals. “I think it could be a potentially groundbreaking medication,

3don MSN

What is Non-Opioid Pain Medication? Journavx Approved by FDA

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

13h

Vertex Pharmaceuticals: Strong Buy Rating Driven by Journavx Approval and Market Expansion Opportunities

Analyst Salveen Richter of Goldman Sachs maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), reducing the price target ...

Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?

Vertex Pharmaceuticals ( VRTX 5.31%) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating cystic ...

At $31 a day, is Vertex’s new non-addictive painkiller worth the price?

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

New non-opioid painkiller Journavx approved by FDA

Related topics